ClariTrial | Search Clinical Trials

Explore/Prostate Cancer

Status

Phase

8,743 results for “Prostate Cancer”

Page 1 of 583

Completed

Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy

Phase 1Phase 2Prostate Cancer

PlaceboAZD5363

University Hospital Southampton NHS Foundation Trust160 participants1 site · United KingdomCompletes Oct 2020

Compare CT.gov Full analysis →

UNKNOWN

Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy

N/AProstate Biopsy

Transperineal mpMRI-US Fusion prostate biopsyTransrectal mpMRI-US Fusion prostate biopsy

Rabin Medical Center76 participants1 site · IsraelCompletes Oct 2019

Compare CT.gov Full analysis →

Completed

Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers

N/APancreatic NeoplasmsStomach NeoplasmsRectal Neoplasms

No Intervention: Observational Cohort

Asan Medical Center32,949 participants1 site · South KoreaCompletes Dec 2022

Compare CT.gov Full analysis →

Recruiting

IDOV-Immune for Advanced Solid Tumors

Phase 1Colorectal CancerPancreatic CancerMelanoma

IDOV-Immune (oncolytic vaccinia virus)

ViroMissile, Inc.78 participants5 sites · United States, AustraliaCompletes Jan 2027

Compare CT.gov Full analysis →

Terminated

Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.

Phase 1Prostate CancerProstate AdenocarcinomaProstate Neoplasm

Abiraterone Oral TabletPrednisone tabletDrug Dairy/Log+1 more

University of Chicago50 participants1 site · United StatesCompletes Nov 2024

Compare CT.gov Full analysis →

Recruiting

24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer

N/ALocalized Prostate Carcinoma

prostate SBRT

IRCCS San Raffaele70 participants1 site · ItalyCompletes May 2028

Compare CT.gov Full analysis →

UNKNOWN

MDPK67b in Patients With Prostate Cancer

Phase 1Prostate Cancer

MDPK67b

Med Discovery SA15 participants1 site · SwitzerlandCompletes Jun 2024

Compare CT.gov Full analysis →

Completed

Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction

Phase 1Phase 2Prostate CancerErectile Dysfunction

injection of bone marrow mononucleated cells

Institut National de la Santé Et de la Recherche Médicale, France18 participants1 site · FranceCompletes May 2012

Compare CT.gov Full analysis →

Active

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Phase 1Advanced or Metastatic Solid TumorsBreast CancerOvarian Cancer

IDE-161Pembrolizumab

IDEAYA Biosciences216 participants27 sites · United StatesCompletes Oct 2026

Compare CT.gov Full analysis →

UNKNOWN

PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System

N/ALocalized Prostate Cancer

Robotic Waterjet Treatment

PROCEPT BioRobotics22 participants3 sites · United StatesCompletes Apr 2025

Compare CT.gov Full analysis →

Completed

CTC Immune Checkpoint

N/AProstate Cancer

CTC biomarker expression prevalence

Duke University38 participants1 site · United StatesCompletes Jun 2019

Compare CT.gov Full analysis →

Completed

Addressing Prostate Cancer Information Disparities With eHealth Technology

N/AProstate Neoplasm

Prostate Cancer Screening Decision Aid

Tufts University125 participants2 sites · United StatesCompletes Aug 2016

Compare CT.gov Full analysis →

Not Yet Recruiting

Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer

Phase 3BRCA-MutatedNeuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate CancerProstate Cancer

Experimental

Gustave Roussy, Cancer Campus, Grand Paris330 participants5 sites · FranceCompletes Sep 2036

Compare CT.gov Full analysis →

Completed

Evaluation of T2, T3 Sympathectomy for Postmastectomy Pain Syndrome by Pulse Oximeter

N/AAnalgesia

Thermal RadiofrequencyChemical Neurolysis

National Cancer Institute, Egypt54 participants1 site · EgyptCompletes Feb 2025

Compare CT.gov Full analysis →

Recruiting

Circulating Tumor DNA in High Risk Localized Prostate Cancer

N/AProstate Cancer

University of Pittsburgh24 participants1 site · United StatesCompletes Sep 2027

Compare CT.gov Full analysis →

1–15 of 8,743

Explore/Prostate Cancer

Status

Phase

8,743 results for “Prostate Cancer”

Page 1 of 583

Completed

Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy

Phase 1Phase 2Prostate Cancer

PlaceboAZD5363

University Hospital Southampton NHS Foundation Trust160 participants1 site · United KingdomCompletes Oct 2020

Compare CT.gov Full analysis →

UNKNOWN

Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy

N/AProstate Biopsy

Transperineal mpMRI-US Fusion prostate biopsyTransrectal mpMRI-US Fusion prostate biopsy

Rabin Medical Center76 participants1 site · IsraelCompletes Oct 2019

Compare CT.gov Full analysis →

Completed

Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers

N/APancreatic NeoplasmsStomach NeoplasmsRectal Neoplasms

No Intervention: Observational Cohort

Asan Medical Center32,949 participants1 site · South KoreaCompletes Dec 2022

Compare CT.gov Full analysis →

Recruiting

IDOV-Immune for Advanced Solid Tumors

Phase 1Colorectal CancerPancreatic CancerMelanoma

IDOV-Immune (oncolytic vaccinia virus)

ViroMissile, Inc.78 participants5 sites · United States, AustraliaCompletes Jan 2027

Compare CT.gov Full analysis →

Terminated

Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.

Phase 1Prostate CancerProstate AdenocarcinomaProstate Neoplasm

Abiraterone Oral TabletPrednisone tabletDrug Dairy/Log+1 more

University of Chicago50 participants1 site · United StatesCompletes Nov 2024

Compare CT.gov Full analysis →

Recruiting

24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer

N/ALocalized Prostate Carcinoma

prostate SBRT

IRCCS San Raffaele70 participants1 site · ItalyCompletes May 2028

Compare CT.gov Full analysis →

UNKNOWN

MDPK67b in Patients With Prostate Cancer

Phase 1Prostate Cancer

MDPK67b

Med Discovery SA15 participants1 site · SwitzerlandCompletes Jun 2024

Compare CT.gov Full analysis →

Completed

Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction

Phase 1Phase 2Prostate CancerErectile Dysfunction

injection of bone marrow mononucleated cells

Institut National de la Santé Et de la Recherche Médicale, France18 participants1 site · FranceCompletes May 2012

Compare CT.gov Full analysis →

Active

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Phase 1Advanced or Metastatic Solid TumorsBreast CancerOvarian Cancer

IDE-161Pembrolizumab

IDEAYA Biosciences216 participants27 sites · United StatesCompletes Oct 2026

Compare CT.gov Full analysis →

UNKNOWN

PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System

N/ALocalized Prostate Cancer

Robotic Waterjet Treatment

PROCEPT BioRobotics22 participants3 sites · United StatesCompletes Apr 2025

Compare CT.gov Full analysis →

Completed

CTC Immune Checkpoint

N/AProstate Cancer

CTC biomarker expression prevalence

Duke University38 participants1 site · United StatesCompletes Jun 2019

Compare CT.gov Full analysis →

Completed

Addressing Prostate Cancer Information Disparities With eHealth Technology

N/AProstate Neoplasm

Prostate Cancer Screening Decision Aid

Tufts University125 participants2 sites · United StatesCompletes Aug 2016

Compare CT.gov Full analysis →

Not Yet Recruiting

Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer

Phase 3BRCA-MutatedNeuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate CancerProstate Cancer

Experimental

Gustave Roussy, Cancer Campus, Grand Paris330 participants5 sites · FranceCompletes Sep 2036

Compare CT.gov Full analysis →

Completed

Evaluation of T2, T3 Sympathectomy for Postmastectomy Pain Syndrome by Pulse Oximeter

N/AAnalgesia

Thermal RadiofrequencyChemical Neurolysis

National Cancer Institute, Egypt54 participants1 site · EgyptCompletes Feb 2025

Compare CT.gov Full analysis →

Recruiting

Circulating Tumor DNA in High Risk Localized Prostate Cancer

N/AProstate Cancer

University of Pittsburgh24 participants1 site · United StatesCompletes Sep 2027

Compare CT.gov Full analysis →

1–15 of 8,743